resiquimod has been researched along with Acute Relapsing Multiple Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battistini, L; Corsetti, M; Gasperini, C; Ruggieri, S; Ruocco, G; Volpe, E | 1 |
| Barbieri, F; Battistini, L; Borsellino, G; Centonze, D; De Bardi, M; Finardi, A; Furlan, R; Gasperini, C; Grasso, MG; Macchiarulo, G; Motta, C; Rossi, S; Ruggieri, S; Ruocco, G; Volpe, E | 1 |
2 other study(ies) available for resiquimod and Acute Relapsing Multiple Sclerosis
| Article | Year |
|---|---|
Resiquimod-Mediated Activation of Plasmacytoid Dendritic Cells Is Amplified in Multiple Sclerosis.
Topics: B7-2 Antigen; Dendritic Cells; HLA-DR Antigens; Humans; Imidazoles; Multiple Sclerosis, Relapsing-Remitting; OX40 Ligand | 2019 |
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Topics: Adult; Case-Control Studies; Cell Communication; Cells, Cultured; Dendritic Cells; Disability Evaluation; Disease Progression; Female; Humans; Imidazoles; Inflammation Mediators; Interferon Regulatory Factors; Interleukin-17; Interleukin-9; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Phenotype; Phosphorylation; Severity of Illness Index; Signal Transduction; STAT1 Transcription Factor; STAT5 Transcription Factor; T-Lymphocytes, Helper-Inducer; Time Factors; Tomography, Optical Coherence | 2015 |